William Aird: Standardizing Anemia, Thrombocytopenia, and Neutropenia Cutoffs
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
“MILD, MODERATE, SEVERE… ACCORDING TO WHO?
I often notice MDs describing cytopenias as “mild,” “moderate,” or “severe” without reference to standard definitions.
The problem? Severity is in the eye of the beholder. Without shared definitions, these terms lose precision.

Of course, no one will argue if you call a platelet count of 143k “mild.”
But in teaching, communication, and especially clinical trials, it’s important to anchor our language to standardized thresholds so we’re all speaking the same language.
The graphic in this tweet summarizes commonly used cutoffs for anemia, thrombocytopenia, and neutropenia, based on guidelines and consensus in the literature.
Clear definitions help keep us on the same page, in both patient care and research!
As much as I endorse standardized definitions, I’d find it more helpful if “severe anemia” aligned better with our transfusion threshold (~7 g/dL). Also, there’s a big difference between a hemoglobin of 7.9 (severe by WHO) and 4.0 in the ED. How ’bout a bit more granularity?”
Stay updated with Hemostasis Today.
-
Jul 17, 2026, 18:20Sarah Jones: Bringing Vessel-on-a-Chip Research to ISTH 2026
-
Jul 17, 2026, 18:06Virginia Barras Sánchez: United by a Commitment to Hemophilia at ISTH 2026
-
Jul 17, 2026, 17:53Micah Grey: Shaping the Future of Hematology at ISTH 2026
-
Jul 17, 2026, 17:32Vasiliki Danilatou: Advancing β-Thalassemia Research at ISTH 2026
-
Jul 17, 2026, 14:4010 Key Topics Presented at EHA2026 Congress
-
Jul 17, 2026, 13:47Clare Martin: Official Launch of the International Working Group for TTP
-
Jul 17, 2026, 13:36Ludwig Traby: Returning to ISTH with a New Perspective on SIC
-
Jul 17, 2026, 13:16Alex Santos: The Best Part Was Never on the Slides
-
Jul 17, 2026, 13:03Gael Morrow: Supporting Career Development at ISTH